Background. Little research exists to guide optimal Chlorhexidine gluconate (CHG) bathing practices. We examined the association between CHG concentrations and methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE), and vancomycin-resistant Enterococcus (VRE) on the skin. Also, we studied whether bioburden is affected by bathing method (2% CHG cloth vs. 4% liquid CHG soap) and time since last CHG bath.
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Sengkang General Hospital, Singapore, ; 2 Singapore General Hospital, Singapore, ; 3 Changi General Hospital, Singapore, ; 4 UNSW, Singapore, ; 5 Yong Loo Lin School of Medicine, Singapore, ; 6 ISAP, Singapore Session: 62. HAI: MRSA Prevention Thursday, October 3, 2019: 12:15 PM Background. Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of healthcare-associated infection. Eradication of MRSA carriage reduces clinical infection and prevents transmission. In Singapore General Hospital, a series of hospital-wide measures were instituted over three years (Figure 1 ) to reduce mupirocin (MUP) resistance, and to decrease the bioburden of MRSA colonization amongst inpatients using octenidine (OCT)-based products.
Methods. A prevalence study was conducted at three time points (TPs) on consecutive MRSA screening isolates to evaluate for their minimum inhibitory concentrations (MICs) to CHG, OCT and MUP using broth microdilution sensitive plates and the presence of the ileS-2 gene, in 2013 (pre-intervention TP, TP1; n = 160), 2016 (early post-intervention TP, TP2; n = 99) and 2017 (late post-intervention TP, TP3; n = 76). Statistical analyses were performed using the Chi-square test with reference from TP1.
Results. A significant improvement in MUP susceptibility by MIC (256 µg/mL) and ileS-2 testing reduced from 25.0% (TP1) to 12.1% (TP2; P = 0.014) to 5.3% (TP3; P = 0.001) and 30.0% (TP1) to 18.2% (TP2; P = 0.036) to 9.2% (TP3; P = 0.001), respectively. OCT MIC range remained stable at 0.5 to 1 across all three TPs. The number of isolates with reduced CHG susceptibility (MIC ≥4 mg/L) increased over the three TPs from 23.1% to 27.2% (P = 0.45) to 42.1% (P = 0.003), despite decreasing CHG prescription.
Conclusion. A restrictive MUP usage policy can improve MUP susceptibility amongst MRSA isolates over time. Widespread OCT use did not appear to result in a rise of OCT MIC over the intervention period. Although the clinical significance of reduced susceptibility to CHG remains uncertain, this worrying trend in our institution deserves further studies to better understand mechanisms of CHG resistance.
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Implementation of a Staphylococcus aureus Screening and Decolonization Program in a Multisite Urban Healthcare System

Background.
Staphylococcus aureus infection confers high mortality. S. aureus-colonized hospitalized patients are more likely to develop invasive infection and can transmit S. aureus to other patients in the absence of symptoms. Our health system has a baseline S. aureus colonization rate of 21% (MSSA and MRSA combined). To reduce risk of invasive S. aureus infection in our patients, we implemented an inpatient S. aureus screening and decolonization program.
Methods. Interventions include universal S. aureus screening and targeted decolonization for all patients on the Medicine and Pediatrics inpatient services. Adult patients are screened at admission and change in the level of care; pediatric patients are screened weekly. S. aureus screening began incrementally by unit between 2016 and 2017, and extended to transplant units in 2018. All cultures are processed in the hospital microbiology lab for identification of MRSA and MSSA. S. aureus decolonization (mupirocin ointment in nares twice daily, chlorhexidine 2% wipes below the chin daily for 5 days) began in 2017 for patients with a central venous catheter, in intensive care
